• Led innovative research on alpha generation by focusing on undervalued intangible assets and analyzing loss-making companies for hidden opportunities.• Pioneered the use of NLP techniques for financial analysis, extracting alpha-generating factors from a variety of financial texts.• Led global exposure analysis on major macro and geopolitical risks, informing strategic asset allocation and risk mitigation for client portfolios.• Spearheaded the design and deployment of scalable, high-performance R Shiny dashboards, powering Investible Strategies.

• Engineered advanced deep learning classification models for fraud analytics, boosting detection accuracy by over 30%.• Designed and deployed a data-driven rating system for Field Collection agents, leading to a 20% increase in target achievement.• Developed sophisticated predictive analytics models for revenue forecasting, reducing forecast errors by 75% and driving a 30% uplift in overall collections.

• Led the design and development of a cross-functional solution for pharmaceutical companies to enable Real-world evidence capabilities.• Led observational studies for Fortune 500 pharma clients, conducting complete studies using EHR and Claims datasets that prevented FDA drug discontinuation.• Engineered cost-cutting strategies that optimized pricing and patient clustering for Pharmaceutical Companies.• Developed a fully automated data analytics platform for unstructured/structured healthcare data, delivering cross-departmental insights via dynamic dashboards.